Daiwa Securities Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Buy
5,455
+1,516
+38% +$138K ﹤0.01% 962
2026
Q1
$379K Sell
3,939
-300
-7% -$30K ﹤0.01% 953
2025
Q4
$412K Buy
+4,239
New +$364K ﹤0.01% 928

Other funds holding IRMD

Daiwa Securities Group's IRMD Position: Q2 2026 in Review

Daiwa Securities Group increased its iRadimed (IRMD) stake by 38% in Q2 2026, buying an estimated $138K and bringing the position to 5,455 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #962.

Daiwa Securities Group first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Daiwa Securities Group held 5,455 shares of iRadimed worth $521K as of Q2 2026.
  • Daiwa Securities Group bought 1,516 iRadimed shares in Q2 2026, an estimated $138K.
  • iRadimed made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #962 holding.
  • Daiwa Securities Group first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.